THE SWARM · FIVE SEATS

Five frontier seats. One rotating judge.

Each model reasons in parallel on the active target. Confidence scores are published with every dossier.

MOST RECENT MISSION

Bicyclic peptides for KRAS G12C inhibition

TARGET
KRAS G12C
MODALITY
Bicyclic peptide
AREA
Non-small cell lung cancer
STATUS
Complete
MODEL 01
✓ DONE
Literature Synthesis
CONFIDENCE
74%
MODEL 02
✓ DONE
Novelty Scout
CONFIDENCE
70%
MODEL 03
✓ DONE
Red Team
CONFIDENCE
76%
MODEL 04
✓ DONE
Patents & Prior Art
CONFIDENCE
65%
MODEL 05
✓ DONE
Adversarial Optimiser
CONFIDENCE
61%